Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.

Baker DG, Diamond BI, Gillette G, Hamner M, Katzelnick D, Keller T, Mellman TA, Pontius E, Rosenthal M, Tucker P, et al.

Psychopharmacology (Berl). 1995 Dec;122(4):386-9.

PMID:
8657838
2.

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic.

Katz RJ, Lott MH, Arbus P, Crocq L, Herlobsen P, Lingjaerde O, Lopez G, Loughrey GC, MacFarlane DJ, McIvor R, et al.

Anxiety. 1994-1995;1(4):169-74.

PMID:
9160569
3.

Predictors of treatment response in patients with posttraumatic stress disorder.

Connor KM, Hidalgo RB, Crockett B, Malik M, Katz RJ, Davidson JR.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):337-45.

PMID:
11294480
4.
5.

MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study.

van Vliet IM, Westenberg HG, Den Boer JA.

Psychopharmacology (Berl). 1993;112(4):483-9.

PMID:
7871061
6.

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Asnis GM, Kohn SR, Henderson M, Brown NL.

Drugs. 2004;64(4):383-404. Review.

PMID:
14969574
7.

Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.

Volz HP, Faltus F, Magyar I, Möller HJ.

J Affect Disord. 1994 Mar;30(3):209-17.

PMID:
8006247
8.

Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine.

Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D'Souza JD, Lofchy J.

J Clin Psychopharmacol. 1993 Dec;13(6):415-22.

PMID:
8120155
10.

Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.

Möller HJ, Volz HP.

Eur Neuropsychopharmacol. 1993 Dec;3(4):501-10.

PMID:
8111223
11.
12.

Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies.

Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA, et al.

Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:426A-427A. No abstract available.

PMID:
1498901
13.

Brofaromine versus imipramine in in-patients with major depression--a controlled trial.

Volz HP, Gleiter CH, Möller HJ.

J Affect Disord. 1997 Jul;44(2-3):91-9.

PMID:
9241569
14.

An open trial of moclobemide in the treatment of post-traumatic stress disorder.

Neal LA, Shapland W, Fox C.

Int Clin Psychopharmacol. 1997 Jul;12(4):231-7.

PMID:
9347385
15.
16.

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.

Lott M, Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Katz RJ, Schaettle SC.

J Clin Psychopharmacol. 1997 Aug;17(4):255-60.

PMID:
9241003
17.

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.

Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR.

Int Clin Psychopharmacol. 2001 Jul;16(4):197-203.

PMID:
11459333
18.

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor.

van Vliet IM, den Boer JA, Westenberg HG.

Eur Neuropsychopharmacol. 1992 Mar;2(1):21-9.

PMID:
1638170
19.

Reversible monoamine oxidase-A inhibitors in panic disorder.

Bakish D, Saxena BM, Bowen R, D'Souza J.

Clin Neuropharmacol. 1993;16 Suppl 2:S77-82.

PMID:
8313401
20.

Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.

Garcia-Borreguero D, Lauer CJ, Ozdaglar A, Wiedemann K, Holsboer F, Krieg JC.

Pharmacopsychiatry. 1992 Nov;25(6):261-4.

PMID:
1494591
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk